HEADER CELL ADHESION 26-OCT-07 2VER TITLE STRUCTURAL MODEL FOR THE COMPLEX BETWEEN THE DR ADHESINS TITLE 2 AND CARCINOEMBRYONIC ANTIGEN (CEA) COMPND MOL_ID: 1; COMPND 2 MOLECULE: AFIMBRIAL ADHESIN AFA-III; COMPND 3 CHAIN: A; COMPND 4 FRAGMENT: RESIDUES 38-160; COMPND 5 SYNONYM: AFAE; COMPND 6 ENGINEERED: YES; COMPND 7 MOL_ID: 2; COMPND 8 MOLECULE: ARCINOEMBRYONIC ANTIGEN-RELATED CELL ADHESION MOLECULE 5; COMPND 9 CHAIN: N; COMPND 10 FRAGMENT: N DOMAIN, RESIDUES 35-144; COMPND 11 SYNONYM: CEA, CARCINOEMBRYONIC ANTIGEN, MECONIUM ANTIGEN 100, CD66E COMPND 12 ANTIGEN; COMPND 13 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: ESCHERICHIA COLI; SOURCE 3 ORGANISM_TAXID: 562; SOURCE 4 STRAIN: DR/AFA; SOURCE 5 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 6 EXPRESSION_SYSTEM_TAXID: 511693; SOURCE 7 EXPRESSION_SYSTEM_STRAIN: BL21; SOURCE 8 MOL_ID: 2; SOURCE 9 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 10 ORGANISM_COMMON: HUMAN; SOURCE 11 ORGANISM_TAXID: 9606; SOURCE 12 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 13 EXPRESSION_SYSTEM_TAXID: 511693; SOURCE 14 EXPRESSION_SYSTEM_STRAIN: BL21 KEYWDS MEMBRANE, FIMBRIUM, GPI-ANCHOR, LIPOPROTEIN, IMMUNOGLOBULIN DOMAIN, KEYWDS 2 CELL ADHESION, CELL PROJECTION EXPDTA SOLUTION NMR MDLTYP MINIMIZED AVERAGE AUTHOR N.KOROTKOVA,Y.YANG,I.LE TRONG,E.COTA,B.DEMELER,J.MARCHANT,W.E.THOMAS, AUTHOR 2 R.E.STENKAMP,S.L.MOSELEY,S.MATTHEWS REVDAT 4 18-MAY-11 2VER 1 VERSN REVDAT 3 24-FEB-09 2VER 1 VERSN REVDAT 2 22-JAN-08 2VER 1 JRNL REVDAT 1 08-JAN-08 2VER 0 JRNL AUTH N.KOROTKOVA,Y.YANG,I.LE TRONG,E.COTA,B.DEMELER,J.MARCHANT, JRNL AUTH 2 W.E.THOMAS,R.E.STENKAMP,S.L.MOSELEY,S.MATTHEWS JRNL TITL BINDING OF DR ADHESINS OF ESCHERICHIA COLI TO JRNL TITL 2 CARCINOEMBRYONIC ANTIGEN TRIGGERS RECEPTOR DISSOCIATION. JRNL REF MOL.MICROBIOL. V. 67 420 2008 JRNL REFN ISSN 0950-382X JRNL PMID 18086185 JRNL DOI 10.1111/J.1365-2958.2007.06054.X REMARK 2 REMARK 2 RESOLUTION. NOT APPLICABLE. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : CNS REMARK 3 AUTHORS : BRUNGER,ADAMS,CLORE,DELANO,GROS, GROSSE- REMARK 3 KUNSTLEVE,JIANG,KUSZEWSKI,NILGES, PANNU,READ, REMARK 3 RICE,SIMONSON,WARREN REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: WATER SHELL REMARK 4 REMARK 4 2VER COMPLIES WITH FORMAT V. 3.20, 01-DEC-08 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 29-OCT-07. REMARK 100 THE PDBE ID CODE IS EBI-34231. REMARK 210 REMARK 210 EXPERIMENTAL DETAILS REMARK 210 EXPERIMENT TYPE : NMR REMARK 210 TEMPERATURE (KELVIN) : 303.0 REMARK 210 PH : 7.0 REMARK 210 IONIC STRENGTH : 2- MM REMARK 210 PRESSURE : 1.0 ATM REMARK 210 SAMPLE CONTENTS : 10% H20/90% D20 REMARK 210 REMARK 210 NMR EXPERIMENTS CONDUCTED : HSQC REMARK 210 SPECTROMETER FIELD STRENGTH : 500 MHZ REMARK 210 SPECTROMETER MODEL : OTHER REMARK 210 SPECTROMETER MANUFACTURER : BRUKER REMARK 210 REMARK 210 STRUCTURE DETERMINATION. REMARK 210 SOFTWARE USED : CNS REMARK 210 METHOD USED : HADDOCK REMARK 210 REMARK 210 CONFORMERS, NUMBER CALCULATED : 200 REMARK 210 CONFORMERS, NUMBER SUBMITTED : 1 REMARK 210 CONFORMERS, SELECTION CRITERIA : REPRESENTATIVE STRUCTURE REMARK 210 REMARK 210 BEST REPRESENTATIVE CONFORMER IN THIS ENSEMBLE : 1 REMARK 210 REMARK 210 REMARK: STRUCTURE WAS DETERMINED USING NMR RESTRAINT DRIVEN REMARK 210 DOCKING (CHEMICAL SHIFTA AND PARAMAGNETIC RELAXATION REMARK 210 ENHANCEMENTS (PRES) REMARK 215 REMARK 215 NMR STUDY REMARK 215 THE COORDINATES IN THIS ENTRY WERE GENERATED FROM SOLUTION REMARK 215 NMR DATA. PROTEIN DATA BANK CONVENTIONS REQUIRE THAT REMARK 215 CRYST1 AND SCALE RECORDS BE INCLUDED, BUT THE VALUES ON REMARK 215 THESE RECORDS ARE MEANINGLESS. REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, N REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 CYS A 3 94.02 -68.67 REMARK 500 ASP A 21 -95.71 60.23 REMARK 500 PRO A 108 103.26 -32.82 REMARK 500 LYS A 123 -118.12 58.61 REMARK 500 ASN A 125 -36.86 65.00 REMARK 500 ALA N 71 -4.30 73.67 REMARK 500 SER N 93 34.95 -79.05 REMARK 500 ASP N 94 19.30 -141.40 REMARK 500 LEU N 95 -38.21 73.91 REMARK 500 VAL N 96 93.24 -69.46 REMARK 500 ASN N 97 40.81 -97.44 REMARK 500 GLU N 98 116.65 -12.82 REMARK 500 REMARK 500 REMARK: NULL REMARK 700 REMARK 700 SHEET REMARK 700 THE SHEET STRUCTURE OF THIS MOLECULE IS BIFURCATED. IN REMARK 700 ORDER TO REPRESENT THIS FEATURE IN THE SHEET RECORDS BELOW, REMARK 700 TWO SHEETS ARE DEFINED. REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE MTN N1111 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE MTN N1112 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE MTN N1113 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 1E07 RELATED DB: PDB REMARK 900 THEORETICAL MODEL OF HUMAN CARCINOEMBRYONIC REMARK 900 ANTIGEN BY HOMOLOGY MODELLING AND CURVE- REMARK 900 FITTING TO EXPERIMENTAL SOLUTION SCATTERING REMARK 900 DATA REMARK 900 RELATED ID: 1UT2 RELATED DB: PDB REMARK 900 AFAE-3 ADHESIN FROM ESCHERICHIA COLI REMARK 900 RELATED ID: 1USZ RELATED DB: PDB REMARK 900 SEMET AFAE-3 ADHESIN FROM ESCHERICHIA COLI REMARK 900 RELATED ID: 2IXQ RELATED DB: PDB REMARK 900 THE SOLUTION STRUCTURE OF THE INVASIVE TIP REMARK 900 COMPLEX FROM AFA-DR FIBRILS REMARK 900 RELATED ID: 1RXL RELATED DB: PDB REMARK 900 SOLUTION STRUCTURE OF THE ENGINEERED PROTEIN REMARK 900 AFAE-DSC DBREF 2VER A 1 123 UNP Q57254 FMA3_ECOLX 38 160 DBREF 2VER N 1 110 UNP P06731 CEAM5_HUMAN 35 144 SEQADV 2VER ASP A 124 UNP Q57254 EXPRESSION TAG SEQADV 2VER ASN A 125 UNP Q57254 EXPRESSION TAG SEQADV 2VER LYS A 126 UNP Q57254 EXPRESSION TAG SEQADV 2VER GLN A 127 UNP Q57254 EXPRESSION TAG SEQADV 2VER GLY A 128 UNP Q57254 EXPRESSION TAG SEQADV 2VER PHE A 129 UNP Q57254 EXPRESSION TAG SEQADV 2VER THR A 130 UNP Q57254 EXPRESSION TAG SEQADV 2VER PRO A 131 UNP Q57254 EXPRESSION TAG SEQADV 2VER SER A 132 UNP Q57254 EXPRESSION TAG SEQADV 2VER GLY A 133 UNP Q57254 EXPRESSION TAG SEQADV 2VER THR A 134 UNP Q57254 EXPRESSION TAG SEQADV 2VER THR A 135 UNP Q57254 EXPRESSION TAG SEQADV 2VER GLY A 136 UNP Q57254 EXPRESSION TAG SEQADV 2VER THR A 137 UNP Q57254 EXPRESSION TAG SEQADV 2VER THR A 138 UNP Q57254 EXPRESSION TAG SEQADV 2VER LYS A 139 UNP Q57254 EXPRESSION TAG SEQADV 2VER LEU A 140 UNP Q57254 EXPRESSION TAG SEQADV 2VER THR A 141 UNP Q57254 EXPRESSION TAG SEQADV 2VER VAL A 142 UNP Q57254 EXPRESSION TAG SEQADV 2VER THR A 143 UNP Q57254 EXPRESSION TAG SEQADV 2VER CYS N 39 UNP P06731 VAL 73 CONFLICT SEQADV 2VER CYS N 43 UNP P06731 ARG 77 CONFLICT SEQADV 2VER CYS N 54 UNP P06731 GLN 88 CONFLICT SEQRES 1 A 143 GLU GLU CYS GLN VAL ARG VAL GLY ASP LEU THR VAL ALA SEQRES 2 A 143 LYS THR ARG GLY GLN LEU THR ASP ALA ALA PRO ILE GLY SEQRES 3 A 143 PRO VAL THR VAL GLN ALA LEU GLY CYS ASN ALA ARG GLN SEQRES 4 A 143 VAL ALA LEU LYS ALA ASP THR ASP ASN PHE GLU GLN GLY SEQRES 5 A 143 LYS PHE PHE LEU ILE SER ASP ASN ASN ARG ASP LYS LEU SEQRES 6 A 143 TYR VAL ASN ILE ARG PRO MET ASP ASN SER ALA TRP THR SEQRES 7 A 143 THR ASP ASN GLY VAL PHE TYR LYS ASN ASP VAL GLY SER SEQRES 8 A 143 TRP GLY GLY THR ILE GLY ILE TYR VAL ASP GLY GLN GLN SEQRES 9 A 143 THR ASN THR PRO PRO GLY ASN TYR THR LEU THR LEU THR SEQRES 10 A 143 GLY GLY TYR TRP ALA LYS ASP ASN LYS GLN GLY PHE THR SEQRES 11 A 143 PRO SER GLY THR THR GLY THR THR LYS LEU THR VAL THR SEQRES 1 N 110 LYS LEU THR ILE GLU SER THR PRO PHE ASN VAL ALA GLU SEQRES 2 N 110 GLY LYS GLU VAL LEU LEU LEU VAL HIS ASN LEU PRO GLN SEQRES 3 N 110 HIS LEU PHE GLY TYR SER TRP TYR LYS GLY GLU ARG CYS SEQRES 4 N 110 ASP GLY ASN CYS GLN ILE ILE GLY TYR VAL ILE GLY THR SEQRES 5 N 110 GLN CYS ALA THR PRO GLY PRO ALA TYR SER GLY ARG GLU SEQRES 6 N 110 ILE ILE TYR PRO ASN ALA SER LEU LEU ILE GLN ASN ILE SEQRES 7 N 110 ILE GLN ASN ASP THR GLY PHE TYR THR LEU HIS VAL ILE SEQRES 8 N 110 LYS SER ASP LEU VAL ASN GLU GLU ALA THR GLY GLN PHE SEQRES 9 N 110 ARG VAL TYR PRO GLU LEU HET MTN N1111 27 HET MTN N1112 27 HET MTN N1113 27 HETNAM MTN S-[(1-OXYL-2,2,5,5-TETRAMETHYL-2,5-DIHYDRO- HETNAM 2 MTN 1H-PYRROL-3-YL)METHYL] METHANESULFONOTHIOATE HETSYN MTN MTSL FORMUL 4 MTN 3(C9 H17 N O S2) HELIX 1 1 ILE N 79 THR N 83 5 5 SHEET 1 AA 7 LEU A 10 ALA A 13 0 SHEET 2 AA 7 GLY A 133 THR A 141 1 O THR A 137 N LEU A 10 SHEET 3 AA 7 GLN A 4 ARG A 6 1 O VAL A 5 N THR A 134 SHEET 4 AA 7 VAL A 28 LEU A 33 -1 O GLN A 31 N ARG A 6 SHEET 5 AA 7 GLY A 93 VAL A 100 -1 O GLY A 94 N VAL A 30 SHEET 6 AA 7 LYS A 64 PRO A 71 -1 O ASN A 68 N TYR A 99 SHEET 7 AA 7 LYS A 53 ILE A 57 -1 O PHE A 54 N VAL A 67 SHEET 1 AB 3 LEU A 10 ALA A 13 0 SHEET 2 AB 3 GLY A 133 THR A 141 1 O THR A 137 N LEU A 10 SHEET 3 AB 3 ASN A 111 ALA A 122 -1 O TYR A 112 N LEU A 140 SHEET 1 NA 4 THR N 3 THR N 7 0 SHEET 2 NA 4 VAL N 17 HIS N 22 -1 O LEU N 18 N THR N 7 SHEET 3 NA 4 LEU N 73 ILE N 75 -1 O LEU N 73 N LEU N 19 SHEET 4 NA 4 GLU N 65 ILE N 67 -1 O ILE N 66 N LEU N 74 SHEET 1 NB 6 ASN N 10 ALA N 12 0 SHEET 2 NB 6 GLU N 99 TYR N 107 1 O ARG N 105 N VAL N 11 SHEET 3 NB 6 GLY N 84 LYS N 92 -1 O GLY N 84 N PHE N 104 SHEET 4 NB 6 LEU N 28 TYR N 34 -1 N PHE N 29 O ILE N 91 SHEET 5 NB 6 GLN N 44 VAL N 49 -1 N ILE N 45 O TRP N 33 SHEET 6 NB 6 CYS N 54 PRO N 57 -1 O CYS N 54 N VAL N 49 SSBOND 1 CYS A 3 CYS A 35 1555 1555 2.03 LINK SG CYS N 39 S1 MTN N1111 1555 1555 2.03 LINK SG CYS N 43 S1 MTN N1112 1555 1555 2.03 LINK SG CYS N 54 S1 MTN N1113 1555 1555 2.03 CISPEP 1 THR N 7 PRO N 8 1 -0.30 SITE 1 AC1 6 MET A 72 CYS N 39 HIS N 89 LEU N 95 SITE 2 AC1 6 ASN N 97 GLU N 99 SITE 1 AC2 2 CYS N 43 PRO N 59 SITE 1 AC3 2 THR N 52 CYS N 54 CRYST1 1.000 1.000 1.000 90.00 90.00 90.00 P 1 1 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 1.000000 0.000000 0.000000 0.00000 SCALE2 0.000000 1.000000 0.000000 0.00000 SCALE3 0.000000 0.000000 1.000000 0.00000